Scientists synthesized inaoside A from mushrooms, unlocking its bioactive potential for functional foods and medicines.

While slurping oysters is not likely to replace popping a pill, they could help in the fight against superbugs. A ...

Appointment of José Antonio Alas brings more than 30 years of biotech expertise, including global business development, ...

While slurping oysters is not likely to replace popping a pill, they could help in the fight against superbugs. A ground ...

An interview on how advanced techniques can be used to enhance silk fibroin and chitosan for drug delivery applications.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's ...

BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

In the following sections, this press release dives into the science behind Mitolyn, shares real-world success stories, and ...

In the broader context of drug discovery, there is a renewed interest in plant-based natural products as sources of new therapeutic agents. Modern approaches in the extraction and development of ...

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an ...

China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why ...